Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau

PR Newswire

BARCELONA, Spain, Nov. 24, 2020 /PRNewswire/ — AlmirallShare, the open innovation platform of Almirall, S.A. (ALM), announces two new collaborations with the University of South Australia and the Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau to find new pathways for the treatment of skin cancer and atopic dermatitis.

Almirall_Logo

The collaboration with Prof. Tarl Prow, Research Professor at Future Industries Institute of the University of South Australia, is focused on generating knowledge about a common type of skin tumor. The aim is to elucidate the molecular mechanisms underlying squamous cell carcinoma and the modulation by a specific treatment. “We are excited to be joining forces with Almirall in this collaborative research project that allows us to establish synergies between different groups to follow our commitment to fight skin cancer. Pairing our deep knowledge of a common type of skin tumor with Almirall’s leading expertise in medical dermatology could reimagine the treatment options for people with skin carcinoma,” said Prof. Tarl Prow.

The project led by Prof. Dr. Lluís Puig, Director of Dermatology Department, and Prof. Silvia Vidal, Coordinator of Inflammatory Diseases Research Area, at Hospital de la Santa Creu i Sant Pau will focus on the understanding of biosignatures operating in atopic dermatitis in the different stages of the disease and in response to systemic therapy. We strongly believe that this collaboration will boost new findings on atopic dermatitis, and it is a further step in future research on new treatments. We are very pleased to be joining forces with a leading medical dermatology company like Almirall,” stated Prof. Dr. Lluís Puig and Prof. Silvia Vidal.

“We are very pleased to start with these two new collaborations and establish close successful partnerships with them. We continue working to empower scientists to improve skin health and fostering collaboration projects with partners worldwide to make a real difference for patients living with skin conditions,” said Maribel Crespo, AlmirallShare leader

AlmirallShare is responsible for approximately 50% of the private-public collaborations driven by Almirall. It facilitates collaborations in dermatological research and accelerate the generation of new treatments for skin conditions. Scientists from anywhere in the world may submit their proposals to submit their proposals responding to the current open calls on sharedinnovation.almirall.com.

 

Cision View original content:http://www.prnewswire.com/news-releases/almirall-announces-collaborations-with-the-university-of-south-australia-and-fundacio-institut-de-recerca-de-lhospital-de-la-santa-creu-i-sant-pau-301179393.html

SOURCE Almirall, S.A.

Union Pacific Corporation CEO Lance Fritz to Address the Credit Suisse 8th Annual Virtual Industrials Conference

PR Newswire

OMAHA, Neb., Nov. 24, 2020 /PRNewswire/ — Lance Fritz, chairman, president and chief executive officer, of Union Pacific Corporation (NYSE: UNP), will address the Credit Suisse 8th Annual Virtual Industrials Conference on Thursday, December 3, 2020, at 8:50 a.m. ET.

A live webcast of the presentation will be available in the investor relations section of Union Pacific’s website at www.up.com/investor. A replay of the audio webcast will be available shortly thereafter.

ABOUT UNION PACIFIC
Union Pacific (NYSE: UNP) delivers the goods families and businesses use every day with safe, reliable and efficient service. Operating in 23 western states, the company connects its customers and communities to the global economy. Trains are the most environmentally responsible way to move freight, helping Union Pacific protect future generations. More information about Union Pacific is available at www.up.com.

www.up.com

www.facebook.com/unionpacific

www.twitter.com/unionpacific

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/union-pacific-corporation-ceo-lance-fritz-to-address-the-credit-suisse-8th-annual-virtual-industrials-conference-301179247.html

SOURCE Union Pacific Corporation

AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference

PR Newswire

NORTH CHICAGO, Ill., Nov. 24, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the Evercore ISI Virtual HealthCONx Conference on Wednesday, December 2 at 1:40 p.m. CT and the Piper Sandler Virtual Healthcare Conference on Thursday, December 3 at 10 a.m. CT. Michael Severino, M.D., vice chairman and president, and Robert A. Michael, executive vice president and chief financial officer, will present at both conferences.

A live audio webcast of each presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the sessions will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Cision View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-conference-and-piper-sandler-healthcare-conference-301179192.html

SOURCE AbbVie

Insmed to Present at the Evercore ISI 3rd Annual HealthCONx Conference

PR Newswire

BRIDGEWATER, N.J., Nov. 24, 2020 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the virtual Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 8:00 a.m. ET.

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the company’s website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed’s first commercial product is a first-in-disease therapy approved in the United States and the European Union to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Argot Partners
Laura Perry or Heather Savelle
(212) 600-1902 
[email protected]   

Media:

Mandy Fahey

Senior Director, Corporate Communications
Insmed
(732) 718-3621
[email protected] 

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-the-evercore-isi-3rd-annual-healthconx-conference-301178239.html

SOURCE Insmed Incorporated

iDENT and Limitless Integrations Adds PATSCAN Platform to its Mobile Onsite Detection System for Stadiums & Event Venues

The iDENT MODSTM to Use Patriot One’s Threat Detection Solutions to Help Instill Event Goer Confidence to Return to Their Favorite Entertainment and Sporting Programs

TORONTO, Nov. 24, 2020 (GLOBE NEWSWIRE) — iDENT LLC and Limitless Integrations LLC announced the launch of the patent pending iDENT MODSTM (Mobile Onsite Detection System) that will include Patriot One Technologies Inc.’s (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One”) PATSCAN Multi-Sensor Threat Detection Platform with specific modules for the early detection of weapons and potential-health related threats, such as viruses. The iDENT MODS unit has been designed to be used in key public gathering locations, such as stadiums, arenas, entertainment venues, and other secure facilities.

Leaders from the entertainment, professional sports, and events industries have expressed great interest in the iDENT MODS units, and its inclusion of the PATSCAN Platform, to ensure a safe and secure environment for their patrons. The solution will be showcased over the next several months, with the intent to restore trust and confidence to their customers and allow staff and talent to return to work and play.

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/5379ef59-b1b1-44a2-b185-fc17ad303d2b

https://www.globenewswire.com/NewsRoom/AttachmentNg/2416a94b-9d0c-40a9-a212-ed96a7789933

The iDENT MODS unit was specifically designed in response to key entertainment and professional sports clients who were looking for an all-inclusive physical threat and health safety solution that could be used to re-open their venues safely and securely. The goal was to minimize time and inconvenience for all event goers, and venue staff at onsite security checkpoints, while providing enhanced safety and security at the venue.

“These iDENT MODS offer event promoters and venue operators a touchless and frictionless security screening process for up to 1800 people per lane per hour,” explained Albert Reynolds, iDENT’s COO and Co-founder. “Our two (2) or six (6) lane units offer great options for front of house or back of house screening to ensure customer, staff and talent safety and security as they attend their favorite programs.”

By incorporating the PATSCAN Platform’s innovative AI-powered threat detection solutions, visitors to event or sports venue can be quickly screened for visible and concealed threats at the outer perimeter of facilities’ plazas, so when entering the secure area all are ensured a great experience. The PATSCAN solutions leverage advanced AI capabilities, correlating data from multiple sensing devices, in near-real time, allowing for very high accuracy, and a pre-emptive approach to minimizing or eliminating risk. By looking for, and identifying risks first, and then identifying individuals, the solution also protects all attendee’s privacy and civil liberties. If a threat is detected, whether associated with weapons, or health risks, onsite security will be immediately notified, and the individual will be flagged for additional screening before gaining access to the stadium or arena.

“Opening up event venues is critical to our communities from both an economic and social perspective,” expressed Peter Evans, CEO of Patriot One, “Incorporating our PATSCAN platform threat detection solutions into these mobile onsite detection units not only provides entertainment, hospitality and retail businesses the opportunity to return to work, but it also provides event goers the confidence that they will be safe and secure as they return to their favorite entertainment and sporting events.”

The iDENT MODS are constructed from mobile shipping containers, which can be transported from one venue to another, and be quickly deployed. Event goers, along with onsite venue staff and talent, simply walk through a mobile checkpoint in 4 simple steps without the need to empty their pockets of keys, cellphones, wallets, change or other personal items.

  • Step 1: As an event attendee approaches the iDENT MODS unit the PATSCAN VRS Weapon & Facial Mask video detection solutions identify potential visible threats in real-time.
  • Step 2: As the attendee passes through the unit, the PATSCAN MSG multi-sensor gateway instantly scans for concealed weapons, such as larger knives, guns and rifles.
  • Step 3: As the concealed weapon scan is taking place, the PATSCAN VRS-T solution scans for elevated body temperature, which may indicate a viral threat.
  • Step 4: As the event attendee prepares to leave the
    iDENT
    MODS unit, they swipe their event ticket across
    the
    contactless ticketing system.
    S
    affire
    Tix and
    blockchain-based
    Health Passport from GetChkd Inc. have combined their technologies to create a portable contactless ticketing solution, which can be linked to an at home or on-site point of care test. Venues could require a negative COVID-19 test, health screening questionnaire, proof of identity and a temperature scan before an event goer and staff can attend and enter a stadium or an arena.
  • Threat Detected? If at any time during this 4-step screening process a threat should be detected, then onsite security are notified in real-time, and can move the individual to a secondary screening areas for further investigation prior to providing event access.

See how simply the
iDENT
MODS Unit works (
click:

www.identmods.com

)

As highlighted above, the unveiling of the iDENT MODS unit will take place over the next few months with iDENT, Patriot One and executives from entertainment, events and sports facilities. Each potential client will see the working iDENT MODS unit and discuss their specific use cases and facility needs.

Respectfully

“Albert Reynolds”

Albert Reynolds, COO & Co-Founder, iDENT LLC

“T.J. Dooley”

T.J. Dooley, CEO & Co-Founder, Limitless Integrations LLC

“Peter Evans”

Peter Evans, CEO, Patriot One Technologies

About
iDENT
LLC

iDENT, LLC was formed to help create a seamless network between those who develop life-saving technology, those who deploy it, and those who can utilize it. Acting as the keystone between technology and application; iDENT has played a vital role in connecting industry-leading companies. Through open communication and exceptional service, we will assist your team in finding the right solution to fit your needs.  We are experts when it comes to designing the safest and most secure environments possible and can handle everything from design & delivery to implementation and servicing. To learn more about iDENT, LLC, visit us on the web at: https://www.identtech.com/ or follow us on social media on Facebook, LinkedIn, Twitter, and Instagram.

About Limitless
Integrations
LLC

Limitless Integrations LLC offers high-quality, reliable commercial/industrial security and safety services in the Ohio/Kentucky/Indiana Tri-State Midwest region. The firm offers reliable and professional security and safety solutions for large venue and private facilities, including the iDENT MODS mobile onsite detection system with partner iDENT LLC of California. The team is made up of highly trained, high quality engineering staff for technology and security system deployments and is committed to providing a comprehensive full suite of services to its clients. To learn more, visit limitlessintegrations.com

About Patriot One Technologies

Patriot One’s mission is to deliver innovative threat detection and counter-terrorism solutions for safer communities. Our PATSCAN™ Multi-Sensor Covert Threat Detection Platform provides a network of advanced sensor technologies with powerful next generation AI/machine learning software. The network can be covertly deployed from far perimeter to interiors across multiple weapons-restricted facilities. The PATSCAN™ platform identifies and reports threats wherever required; car park, building approach, employee and public entryways and inside the facilities. Each solution in the platform identifies weapons, related threats or disturbances, or potential health and safety threats for immediate security response. Our motto Deter, Detect and Defend is based on the belief that widespread use of the PATSCAN™ platform will act as an effective deterrent to diminish the epidemic of active threats around the globe. For more information, visit: www.patriot1tech.com or follow us on Twitter and Facebook.

For further information, please contact:

iDENT
Sales

Albert Reynolds, III, Sales

[email protected]

916-529-5715

Eli Covell, Sales

[email protected]

530-412-0400

iDENT
Investor Relations

Mark
Cordano
, Investor Relations

[email protected]

916-600-4245

iDENT
Marketing

Brett
Aitkenhead
, Media/Marketing

[email protected]

619-307-3839

iDENT
Email us at [email protected]
Main Office: 916-741-3311

Limitless Integrations LLC

T.J. Dooley, CEO & Co Founder
+1-513-319-9986

Patriot One Investor Relations

John Martin, Patriot One Technologies
+1 (888) 728-1332
[email protected]

Patriot One Media Contacts:

Scott Ledingham, Patriot One Technologies
+1-613-806-7135
[email protected]

Patriot One Technologies Inquiries

[email protected]
www.patriot1tech.com

CAUTIONARY DISCLAIMER STATEMENT:
No securities exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to system sales, product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects”,” believes”, and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include counterparty default and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements only as expressly required by applicable law.

Neither the Toronto Stock Exchange (TSX) nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.



Kiniksa Pharmaceuticals to Present at the Evercore ISI 3rd Annual HealthCONx Conference

HAMILTON, Bermuda, Nov. 24, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1st, 2020 at 8:50 a.m. Eastern Time.

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa’s website for 14 days following the conference.

About Kiniksa

Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s product candidates, rilonacept, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions, and offer the potential for differentiation. These pipeline assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visit www.kiniksa.com.


Every Second Counts!™

Kiniksa Investor and Media Contact

Mark Ragosa
(781) 430-8289
[email protected]



Uber Partners with Bond Brand Loyalty to Bring Last-Mile On-demand Delivery ahead of Holiday Rush

Uber Canada launches Direct, an unmatched real-time delivery solution that reduces fulfillment to hours vs. days

TORONTO and NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) — Uber announced today the introduction of Uber Direct, a new and operationally efficient way for Canadian retailers to manage their delivery process, reach their customers, and quickly deliver right to their doorstep—without contact. Ahead of the holiday season, a much-needed evolution of e-commerce and fulfillment, Uber is also pleased to announce its collaboration with Bond Brand Loyalty, Inc. to bring a new purchase and redemption experience to brands and their clients’ millions of reward program members.

The transformative solution that leverages Uber Direct’s technology allows retail e-commerce and loyalty program operators to meet customers’ rising expectations for fast and convenient delivery. Customers who make purchases or redeem loyalty points for rewards can have their items delivered within hours versus days via traditional delivery methods.

Uber Direct builds upon Uber Eats’ recent expansion into grocery and convenience-store delivery. Retailers and manufacturers can now leverage Uber’s technology as an operationally efficient way to move goods between locations and into the hands of customers. With the scale and reliability of Uber, Bond is setting a new standard of fulfillment and delivery, connecting the last mile of e-commerce with loyalty.

“With the pandemic, delivery has evolved from a luxury to a utility as businesses look for—and consumers expect—real-time fulfillment,” said Ronnie Gurion, General Manager, Uber for Business. “We’re pleased to partner with Bond Brand Loyalty to accelerate their delivery standard for loyalty point rewards from days to within hours.”

“Solving complex customer challenges in this new norm requires new approaches and innovative digital solutions that give consumers confidence that their items are assuredly en route, and a rewarding immediate gratification feeling,” said Sean Claessen, Chief Strategy Officer for Bond. “By combining Bond’s leading customer experience and loyalty thinking and platform with Uber’s best-in-class technology, we’re ushering in a new era of customer experience. This move is part of the next step in Bond’s broader customer-linking plans and we are exceedingly excited about the road ahead with Uber.”  

Research shows that consumers will form new brand loyalties based on availability and delivery speed. Nearly three-quarters (74%) of consumers surveyed said same-day delivery increased their brand loyalty. In addition, Bond’s Loyalty Report found that the top drivers of loyalty when it comes to redemption include ease of the redemption process and time it takes to receive redeemed rewards (a 6.8X satisfaction lift).

Consumers have prioritized convenience and immediacy for years, declaring in research that nearly a third of them are entirely willing to pay a premium for an increased level of service. And our pilot with Uber confirms the attitudinal data holds true in real life, with consumers demonstrating significantly higher satisfaction, two-fold (2X) promoters in NPS scoring, and an increased propensity to repeat a transaction like this again.

Having already worked to integrate Uber rides and eats into the rewards experience of several major bank credit card reward portfolios, popular consumer engagement programs, contests, and promotions, Bond is excited to bring a better experience to customers now in delivery and fulfilment of other items they’re after—with the scale, reliability, and convenience of Uber.

To learn more, read our latest blogpost A CX Game-Changer Puts Loyalty in The Fast Lane.

About Bond
Bond Brand Loyalty, Inc. solves complex customer challenges with a unique blend of human-centered design, data science, and loyalty mechanics that transforms how brands win, serve, and keep customers. Working globally with iconic brands, Bond designs, builds, and operates digital and human experiences that create measurable, authentic, and long-lasting relationships through a combination of solutions that includes customer experience design, loyalty consulting and management, CRM and digital marketing, research and analytics, channel and employee engagement, and program technology and platforms. For more information, visit bondbrandloyalty.com, follow Bond on LinkedIn and Twitter, or connect by phone at 1-844-277-2663.

About Uber

Uber’s mission is to create opportunity through movement. We started in 2010 to solve a simple problem: how do you get access to a ride at the touch of a button? More than 15 billion trips later, we’re building products to get people closer to where they want to be. By changing how people, food, and things move through cities, Uber is a platform that opens up the world to new possibilities.

For more information, please contact:

Richard Lane
Bond Brand Loyalty
[email protected]

Laura Miller 
Uber Canada
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/981924e0-5074-4898-ac03-18f03d7ad49c 



MJardin Provides U.S. Operations Update

TORONTO and DENVER, Nov. 24, 2020 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that as part of its ongoing review, evaluation and turnaround process, it has terminated certain management services agreements and consulting agreements (“MSAs”) with parties located in Denver, Colorado, effective immediately.

Following this announcement and the disclosure contained in the Company’s press release dated March 31, 2020, the Company will no longer have any active MSAs in Colorado.

The MSAs between the Company and 3B Ventures, LLC and TwoG Ventures, LLC, (together, the “Clients”) will be terminated, on the consent of the parties, effective immediately. The termination of the MSAs with the Clients will not affect the promissory notes, intellectual property agreements and lease obligations currently in place between the Clients and MJardin.

Termination of the MSAs will substantially reduce U.S. segment revenues and ongoing management obligations, thus reducing costs, which will place fewer cash flow demands on MJardin. The Company remains committed to exploring growth opportunities in the Colorado market while maintaining strict discipline in its approach to capital deployment.

About MJardin Group

MJardin Group’s mission is to set the standard for successful ownership of assets in the cannabis industry. Our founders spent a decade refining cultivation methodology, collecting and implementing data driven standards and designing state of the art facilities. Today, MJardin owns multiple operations in Canada, supplying the market with premium products. We are committed to our Canadian First Nation joint ventures and all our strategic partnerships across the cannabis supply chain. MJardin is publicly listed on the CSE (MJAR) and the QXOTC (MJARF) with offices in Toronto, Ontario and Denver, Colorado.

The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may’, ‘will’, ‘should’, ‘could’, ‘would’, ‘expects’, ‘intends’, ‘plans’, ‘anticipates’, ‘believes’, ‘estimates’, ‘projects’, ‘predicts’, ‘potential’, ‘outlook’ or ‘continue’ or the negative of those forms or other comparable terms. Statements about, among other things, future developments in the business and operations of MJardin, contain forward-looking information. These statements should not be read as guarantees of future performance or results. The Company’s forward-looking information and forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information and forward-looking statements, including but not limited to: our ability to identify and pursue growth, financing and other strategic objectives, and the regulatory and economic environments in the jurisdictions we operate or intend to operate or invest in. Reference should also be made to the risks and uncertainties which are discussed in greater detail in the “Risk Factors” section of the Company’s Annual Management’s Discussion and Analysis filed on SEDAR and as described from time to time in documents filed by the Company with Canadian securities regulatory authorities. Readers are cautioned that the foregoing list of factors is not exhaustive. Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that any proposed transactions will occur or that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information and forward-looking statements. Accordingly, readers should not place undue reliance on the forward-looking information and forward-looking statements. No assurances are given as to the future trading price or trading volumes of MJardin’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking information and forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise. MJardin assumes no responsibility to update or revise forward-looking information and forward-looking statements to reflect new events or circumstances unless required by applicable law.

Caution Regarding Cannabis Operations in the United States

Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under US federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in the United States is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect the Company’s operations and financial performance.

INVESTOR CONTACT:
     
Ali Mahdavi   Pat Witcher
Capital Markets & Investor Relations   Chief Executive Officer
416-962-3300   720-613-4019
[email protected]     

 



Magna Brings EyeQ5-Based Driver Assistance System to Market

  • One of the industry’s first “one-box” EyeQ5 front-facing camera systems
  • Magna’s electronics and camera expertise, Mobileye’s image-processing technology
  • Magna ADAS systems are found on more than 250 vehicle models on the road today

TROY, Mich., Nov. 24, 2020 (GLOBE NEWSWIRE) — A premium automaker in Europe will soon be able to offer industry-leading driver assistance features across a larger portion of its vehicle lineup, thanks to the next generation of camera-based driver assistance from Magna.

The Magna Gen5 “one-box” solution is a Mobileye EyeQ5-based system – one of the industry’s first where the forward-facing camera and related software are contained in a single assembly. Benefits include lower cost, simplified installation on the assembly line, and the ability for the technology to be applied to a wider range of an automaker’s lineup. The system will provide drivers with safety and convenience features such as adaptive cruise control, automatic emergency braking and pedestrian detection. 

As with previous generations, the system combines Magna’s electronics and camera expertise with Mobileye’s system-on-chip (SoC) image-processing technology. The camera features a 120-degree, 8-megapixel optical path, while Magna has continued to refine its world-class camera manufacturing processes to achieve the quality and volumes required of global vehicle platforms. Mobileye collaborated with Magna engineers to ensure that the EyeQ5 met and exceeded new requirements related to the launch program.

“At Magna, our ADAS capability has been built on automotive cameras, evidenced by more than 500 U.S. patents in the last 15 years,” said Uwe Geissinger, President of Magna Electronics. “As demonstrated by our long collaboration with Mobileye and the introduction of our new Gen5 system, we’re constantly working to deliver innovative systems to our customers and help make vehicles safer and more enjoyable to drive.”

“We have been working with Magna on camera-based ADAS since 2007, and our collaboration continues to provide leading-edge driver-assistance features,” said Erez Dagan, Executive Vice President for Products and Strategy at Mobileye. “This latest system represents a new level of performance and functionality, and we’re already looking for ways to make subsequent generations even better.”

Magna provides global automakers with ADAS technologies – including the PACE Award-winning Trailer Angle Detection, Automatic Emergency Braking, and rearview object and pedestrian detection – to more than 250 vehicle models on the road today.

TAGS
Automotive camera systems, camera-based ADAS, automotive electronics

INVESTOR CONTACT
Louis Tonelli, Vice President, Investor Relations
[email protected], (+1) 905.726.7035

MEDIA CONTACT
Tracy Fuerst, Vice President, Corporate Communications & PR
[email protected], (+1) 248.631.7004

ABOUT MAGNA
We are a mobility technology company. We have over 157,000 entrepreneurial-minded employees, 344 manufacturing operations and 93 product development, engineering and sales centres in 27 countries. We have complete vehicle engineering and contract manufacturing expertise, as well as product capabilities that include body, chassis, exteriors, seating, powertrain, active driver assistance, electronics, mechatronics, mirrors, lighting and roof systems. Our common shares trade on the Toronto Stock Exchange (MG) and the New York Stock Exchange (MGA). For further information about Magna, visit www.magna.com.

THIS RELEASE MAY CONTAIN STATEMENTS WHICH CONSTITUTE “FORWARD-LOOKING STATEMENTS” UNDER APPLICABLE SECURITIES LEGISLATION AND ARE SUBJECT TO, AND EXPRESSLY QUALIFIED BY, THE CAUTIONARY DISCLAIMERS THAT ARE SET OUT IN MAGNA’S REGULATORY FILINGS. PLEASE REFER TO MAGNA’S MOST CURRENT MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL POSITION, ANNUAL INFORMATION FORM AND ANNUAL REPORT ON FORM 40-F, AS REPLACED OR UPDATED BY ANY OF MAGNA’S SUBSEQUENT REGULATORY FILINGS, WHICH SET OUT THE CAUTIONARY DISCLAIMERS, INCLUDING THE RISK FACTORS THAT COULD CAUSE ACTUAL EVENTS TO DIFFER MATERIALLY FROM THOSE INDICATED BY SUCH FORWARD-LOOKING STATEMENTS. THESE DOCUMENTS ARE AVAILABLE FOR REVIEW ON MAGNA’S WEBSITE AT 

WWW.MAGNA.COM

.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cf925241-95aa-4512-be68-d2071c01bcb3



Centro Rossi Implements Konica Minolta Healthcare’s Exa Platform Across Multiple Centers in Argentina

WAYNE, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) — Konica Minolta Healthcare Americas, Inc. announces that Centro Rossi, a leading healthcare provider in Argentina with 13 locations throughout Greater Buenos Aires, is implementing the Exa® Enterprise Imaging Platform throughout all of its centers. Konica Minolta also announced an agreement with Habitat Evolution to distribute the Exa Enterprise Imaging Platform within all regions of Argentina.

Founded by Dr. Enrique Martín Rossi in 1980, Centro Rossi has led the modernization of diagnostic imaging services and elevated the quality of care in Argentina by acquiring state-of-the-art systems and retaining highly trained staff. The organization selected the Exa Platform because it is customizable and adaptable to the specific needs of the region. Konica Minolta and Centro Rossi will collaborate to continue enhancing and evolving the Exa Platform for the Latin American market.

“At Centro Rossi, we consistently seek the best solutions to provide our patients with the highest standard of care,” says Santiago Enrique Rossi, MD, Medical Director at Centro Rossi. “The Exa Enterprise Imaging Platform will help us provide better care for our patients and referring physicians and we are very proud to work with Konica Minolta to further innovate and bring new imaging informatics solutions to the Latin American healthcare market.

The Exa Platform is designed to allow for the rapid adoption of new technologies and capabilities as customer and market needs evolve. With a web-based, Zero-Footprint platform, the Exa Platform uses Server-Side Rendering to facilitate the fast transfer of large imaging studies regardless of the internet connection. The diagnostic-quality Zero Footprint viewer provides access to patient data from any device and from any location with an internet connection. As a leader in the region, Centro Rossi is uniquely positioned to provide insights on the strategic direction of Healthcare IT in Latin America.

“As we introduce Konica Minolta’s Healthcare IT solutions to the region, this partnership provides new opportunities to innovate our Exa Enterprise Imaging Platform and introduce new technologies to meet the unique and evolving needs of the local market. Centro Rossi’s patient-centric business model aligns with ours and we are very excited to enter into this strategic partnership with one of the most prestigious imaging center organizations in Latin America,” says Antonio Uzcátegui, Director of Health Technology for Latin America at Konica Minolta Healthcare Americas, Inc.

Regarding the partnership with Habitat Evolution, Daniela Prosperi, Director of Operations for Habitat Evolution, says signing a distribution agreement with a multinational company like Konica Minolta Healthcare underscores the importance of developing markets even in the midst of a difficult business climate. “It’s all about innovation, and this is only the first step of many to come with this collaboration,” adds Prosperi. “The Habitat Evolution team is proud and committed to make this partnership a complete success.”

Ernesto Márquez, General Manager of the Latin American Region for Konica Minolta Healthcare, expressed his enthusiasm for the new distributor partnership. “Habitat Evolution’s experienced professionals are uniquely qualified to collaborate with our organization to further develop our Healthcare IT business footprint in Argentina.”

About Konica Minolta Healthcare Americas, Inc.

Konica Minolta Healthcare is a world-class provider and market leader in medical diagnostic imaging and healthcare information technology. With over 75 years of endless innovation, Konica Minolta is globally recognized as a leader providing cutting-edge technologies and comprehensive support aimed at providing real solutions to meet customer’s needs and helping make better decisions sooner. Konica Minolta Healthcare Americas, Inc., headquartered in Wayne, NJ, is a unit of Konica Minolta, Inc. (TSE:4902). For more information on Konica Minolta Healthcare Americas, Inc., please visit www.konicaminolta.com/medicalusa.

Contact: 
Mary Beth Massat                                                        
Massat Media
224.578.2388
www.konicaminolta.com/medicalusa